Journal
ANTIOXIDANTS & REDOX SIGNALING
Volume 14, Issue 7, Pages 1237-1243Publisher
MARY ANN LIEBERT INC
DOI: 10.1089/ars.2010.3385
Keywords
-
Funding
- European Community [NoE/512032]
- Fundacion La Caixa
- MICINN
- CIBERNED
Ask authors/readers for more resources
DREAM/KChIP3 (Downstream Regulatory Element Antagonist Modulator) is a multifunctional Ca2+-binding protein that acts in the nucleus as a Ca2+-dependent transcriptional repressor. Binding to DNA and repressor activity of DREAM is regulated by Ca2+, specific post-translational modifications as well as by protein-protein interactions with several nucleoproteins. Here, using the yeast two-hybrid assay, we characterized the interaction of DREAM with peroxiredoxin 3 (Prdx3), an antioxidant enzyme that uses the thioredoxin system as electron donor. Importantly, the DREAM/Prdx3 interaction is Ca2+ dependent and is blocked by DTT. Coexpression of Prdx3 enhances DREAM binding to DRE sites and its repressor activity in vivo. Two cysteine residues in the N-terminal domain of DREAM are responsible for the redox modulation of its activity. Double Cys to Ser substitution results in a mutant DREAM with stronger repressor activity. Finally, we show that transient DREAM knockdown sensitizes PC12 cells to H2O2-induced oxidative stress, suggesting a protective role for DREAM against oxidative damage. Antioxid. Redox Signal. 14, 1237-1243.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available